Baveno VII – Renewing consensus in portal hypertension
2021 · Journal of Hepatology · 2,388 citations
https://doi.org/10.1016/j.jhep.2021.12.022
J
Joan Genescà
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
342
Papers
15.8K
Citations
58
h-index
135
i10-index
Joan Genescà is an academic researcher from Hebron University. The author has contributed to research in topics: Liver Disease Diagnosis and Treatment & Liver Disease and Transplantation & Hepatitis C virus research. The author has an h-index of 58, co-authored 291 publications.
ORCID: 0000-0002-0831-8422Papers by this author
worksA MELD-Based Model to Determine Risk of Mortality Among Patients With Acute Variceal Bleeding
2013 · Gastroenterology · 386 citations
https://doi.org/10.1053/j.gastro.2013.10.018
Noninvasive tools and risk of clinically significant portal hypertension and varices in compensated cirrhosis: The “Anticipate” study
2016 · Hepatology · 363 citations
https://doi.org/10.1002/hep.28824
Expanding the Baveno VI criteria for the screening of varices in patients with compensated advanced chronic liver disease
2017 · Hepatology · 264 citations
https://doi.org/10.1002/hep.29363
Rebleeding and mortality risk are increased by ACLF but reduced by pre-emptive TIPS
2020 · Journal of Hepatology · 183 citations
https://doi.org/10.1016/j.jhep.2020.04.024
Total area of spontaneous portosystemic shunts independently predicts hepatic encephalopathy and mortality in liver cirrhosis
2020 · Journal of Hepatology · 148 citations
https://doi.org/10.1016/j.jhep.2019.12.021
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat